William E. Rote, Senior Vice President, R&D at Travere Therapeutics, Inc. (TVTX), sold 1,875 shares at $24.98 ($47K) on 2022-01-24, disclosed to the SEC on 2022-01-26.
Scheduled sale ($47k) by Senior Vice President, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TVTX | SELL | 2026-04-23 | $356K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $409K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $2.4M | — | Filing → |